Key result
First- and second-generation antipsychotic use was not associated with unexplained sudden deaths in psychiatric patients, whereas comorbid dyslipidemia and diabetes were more common (P=0.006).
Why the study?
Are unexplained sudden deaths in psychiatric patients associated with higher utilization of antipsychotics compared to explained sudden deaths?
Population
100 adults with sudden death receiving care in one large psychiatric hospital in New York over a 26-year…
Comparison
Unexplained sudden death (n=52) vs Explained sudden death (n=48)
Design
Cohort
Follow-up
26-year period (1984-2009)
Authors
Loading...
Unexplained sudden deaths in psychiatric patients appear to be associated with metabolic risk factors like diabetes and dyslipidemia rather than the use of antipsychotic medications.
Cohort (n=100)
No
Are unexplained sudden deaths in psychiatric patients associated with higher utilization of antipsychotics compared to explained sudden deaths?
Unexplained sudden deaths in psychiatric patients appear to be associated with metabolic risk factors like diabetes and dyslipidemia rather than the use of antipsychotic medications.
Manu et al. (2011) conducted a cohort in Psychiatric patients (n=100). First- and second-generation antipsychotics vs. Non-users was evaluated on Utilization of first- or second-generation antipsychotics in unexplained versus explained sudden death cases. First- and second-generation antipsychotic use was not associated with unexplained sudden deaths in psychiatric patients, whereas comorbid dyslipidemia and diabetes were more common (P=0.006).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: